Savior Lifetec Corporation (TPEX:4167)
20.75
+0.10 (0.48%)
Oct 20, 2026, 1:30 PM CST
Savior Lifetec Revenue
Savior Lifetec had revenue of 285.94M TWD in the quarter ending June 30, 2026, a decrease of -14.77%. This brings the company's total for the last twelve months to 1.12B, down -7.19% year-over-year. In the year 2025, Savior Lifetec had annual revenue of 1.20B, down -1.28%. That makes Savior Lifetec the 30,463rd largest company in the world by revenue and 1,504th in Taiwan.
Revenue (ttm)
1.12B
Revenue Growth
-7.19%
P/S Ratio
6.13
Revenue / Employee
2.92M
Employees
384
Market Cap
6.88B
Revenue by Geography
- America 784.64M 65.3%
- Taiwan 193.63M 16.1%
- Asia 89.15M 7.4%
- Europe 70.94M 5.9%
- Other 63.33M 5.3%
Fiscal year ended Dec 31, 2025 See the full Savior Lifetec breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.20B | -15.64M | -1.28% |
| Dec 31, 2024 | 1.22B | 167.05M | 15.91% |
| Dec 31, 2023 | 1.05B | -215.47M | -17.02% |
| Dec 31, 2022 | 1.27B | -478.04M | -27.41% |
| Dec 31, 2021 | 1.74B | -83.46M | -4.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sinphar Pharmaceutical | 3.45B |
| Adimmune | 1.37B |
| PharmaEngine | 1.03B |
| Tanvex BioPharma | 657.56M |
| TaiGen Biopharmaceuticals Holdings | 256.46M |
| Polaris Group | 67.95M |
| OBI Pharma | 52.20M |
| Locus Cell | 19.40M |